Shares of Oscar Health, Inc. (OSCR) soared 11.37% during Tuesday's intraday trading session, marking a significant upward movement for the healthcare technology company.

The surge comes as investors focused on the company's optimistic financial guidance for the full year 2026, projecting revenue between $18.7 billion and $19.0 billion and earnings from operations in the range of $250 million to $450 million. This positive outlook, which signals a targeted return to profitability, overshadowed a fourth-quarter 2025 performance that missed analyst estimates for both revenue and earnings.

Further bolstering investor sentiment was the announcement that Oscar Health entered into a new $475 million secured revolving credit facility on February 6, 2026. Management stated this move strengthens the company's balance sheet and provides financial flexibility to support its long-term growth strategy, effectively shifting the market's focus from recent quarterly challenges to future potential.